Role of p53 in the Regulation of Cellular Senescence
Open accessThe DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
The p53 transcription factor plays a critical role in cellular responses to stress. Its activation in response to DNA damage leads to cell growth arrest, allowing for DNA repair, or directs cellular senescence or apoptosis, thereby maintaining genome integrity. Senescence is a permanent cell-cycle arrest that has a crucial role in aging, and it also represents a robust physiological antitumor response, which counteracts oncogenic insults. In addition, senescent cells can also negatively impact the surrounding tissue microenvironment and the neighboring cells by secreting pro-inflammatory cytokines, ultimately triggering tissue dysfunction and/or unfavorable outcomes. This review focuses on the characteristics of senescence and on the recent advances in the contribution of p53 to cellular senescence. Moreover, we also discuss the p53-mediated regulation of several pathophysiological microenvironments that could be associated with senescence and its development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Induction and initiation of cellular growth control and senescence via p53 or P16INK4A pathways. Various internal or external stress factors trigger the DNA-damage response (DDR) pathway, which in turn activates the p53 and/or the p16INK4A pathways. p16INK4A inactivates Cdk4/6, results in accumulation of phosphorylated pRb, stops the regulation of E2F transcription factors, and drives cell cycle arrest or senescence. These stressors also trigger DNA damage (cellular responses to such damages are regulated by either ATM-Chk2 or ATR-Chk1 pathways) and transactivate p53 and p21CIP1. Moreover, p21CIP1 protein levels may lead to the inhibition of Cdk4/6 activity, which contribute to the G1 arrest or senescence [33,34].](https://figures.cochat.ai/paper-figures/73d1c8e4b31243a49a8fdf24b567946a/role-of-p53-in-the-regulation-of-cellular-senescence-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Senescence is driven by the tumor-suppressor pathways p53-p21CIP1 and p16INK4a-Rb,19,20,21”
From Cellular senescence in human liver under normal aging and cancer (2026) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“with CDKN2A (p16INK4a) and CDKN1A (p21CIP1) serving as canonical senescence markers.”
From Cellular senescence in human liver under normal aging and cancer (2026) · cites this paper as [19]
In the citing paper
“The p16INK4A/Rb pathway also plays a critical role in senescence. CDK4/6 are inactivated by p16INK4A, promoting the accumulation of phosphorylated Rb and the inactivation of E2F transcription, which induces senescence.66”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [66]
In the citing paper
“p16INK4A inactivates Cdk4/6, phosphorylates Rb accumulation and inactivates E2F transcription, leading to cell cycle arrest or senescence.85”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [85]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 1×
“Cellular senescence is a physiological mechanism adopted by cells to limit tumorigenesis [99,100], and for this reason, a therapy-induced senescence was considered as an alternative and possibly safer approach to the traditional cancer therapy, which aimed at inducing extensive DNA damage [101].”
BackgroundInflammatory responses and inflammation-associated diseases in organs
Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., Li, Y., Wang, X., & Zhao, L. (2018) · Oncotarget · doi:10.18632/oncotarget.23208 · Cited by 5,143 · cited 1×
“It is responsible for many chronic diseases, including cardiovascular and bowel diseases, diabetes, arthritis, and cancer [114,115].”
BackgroundIn Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · cited 2×
“Many recent studies actually demonstrated how many OIS pathways can actually activate p53 bypassing the DDR: Ras through NOREA1, which promotes the pro-senescence acetylation of p53 while inhibiting its pro-apoptotic phosphorylation, AKT through the downregulation of MnSOD, onco-suppressor PTEN depletion, inducing mTO…”
BackgroundCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 2×
“Cellular senescence is defined as a cell state characterized by prolonged and generally irreversible cell-cycle arrest [14] and the acquisition of different phenotypic alterations, including morphological changes, chromatin remodeling, metabolic reprogramming, and secretion of pro-inflammatory factors or SASP (senesce…”
BackgroundBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · cited 1×
“This impressive number is a reflection of the many—sometimes alternative—roles p53 can play; in fact, several of these genes are known to be involved in the regulation of metabolism, autophagy, DNA damage repair, cell cycle arrest, quiescence, senescence, and apoptosis [35].”
BackgroundThe role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379 · cited 1×
“However, once p16 is highly expressed, downregulation of p53 cannot reverse cell cycle arrest [58].”
BackgroundCellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“Stressors include both intrinsic factors, such as oxidative damage, telomere attrition, hyperproliferation, oncogene activation, and environmental sources, including UV-light, γ-irradiation, and chemotherapeutic drugs [18,19].”
BackgroundOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086 · cited 1×
“They also reported co-localization of IL-8 and senescence markers in human colon adenomas [42].”
Background
Cited by
Items 601–640 of 640
Son, H.-J., Lee, G., Ryu, Y., Noh, K. B., Hwang, J. S., Oh, S., & Shin, Y. J. (2026) · Translational Vision Science & Technology · doi:10.1167/tvst.15.6.23
“The elevation of p53 levels in TGF-β –treated cells, a key regulator of cell cycle arrest and senescence, 60,68 was significantly reduced by miR-196a.”
Liu, Z., Wang, M., Sun, J., Lee, W., Tsang, H. Y., Chow, K. T., & Sun, D. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6c05873
Park, S., & Ahn, B. Y. (2026) · Nutrients · doi:10.3390/nu18142278
“This pathway plays a pivotal role in maintaining cellular integrity, orchestrating processes such as cell cycle arrest, DNA repair, and apoptosis [36,37].”
Wang, X., Ning, M., Wang, H., Li, J., Xie, X., Xie, H., Li, L., Sun, X., Lu, L., Zhang, Y., et al. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112737
Multifaceted roles of Isthmin-1 in health and disease: mechanism and therapeutic intervention
Wei, Y. M., Wu, W., Hou, Y., Zhang, Y., Zhao, K., & Ding, W. (2026) · Clinical Science · doi:10.1042/cs20260727
Tao, Z., Guo, C., Xu, S., Xiao, X., Yang, B., Wang, S., Skalny, A. V., Tinkov, A. A., Aschner, M., & Lu, R. (2026) · NeuroToxicology · doi:10.1016/j.neuro.2026.103528
Precision prime editing of TP53 mutations for functional tumor suppression in colorectal cancer
Azhar, M., Malviya, R., Chandra, P., Sridhar, S. B., Shareef, J., & Wadhwa, T. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154311
What Is the Role of Endothelial Cells in Cerebral Blood Flow Dysregulation in Small Vessel Disease?
Benarroch, E. E. (2026) · Neurology · doi:10.1212/wnl.0000000000218477
Characterisation of a novel p53 mutation (p53N263Tfs*7) associated with li-fraumeni syndrome
Wright, F. M., Vasileva‐Slaveva, M., Yordanov, A. D., Ivanov, I. F., Gorcheva, Z., Mohr, A., Wright, G. S. A., Brooke, G. N., & Metodiev, M. V. (2026) · BMC Cancer · doi:10.1186/s12885-026-16582-2
“This leads to the induction of genes involved in cell cycle arrest, apoptosis, DNA repair, and senescence [64].”
Endothelial cell–pericyte interactions in ischemic stroke: From microvascular pathology to repair
Feng, S., Zhang, C., Zhao, Y., Wang, Y., 张柏民, Zhang, Q., Zheng, Y., Cheng, F., Li, C., Wang, X., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108351
Complosome as a key modulator of cellular senescence, aging and age-related diseases
Gold, N. M., Okeke, M. N., Ewhea, A. S., & He, Y. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103274 · Cited by 1
Campagnoli, L. I. M., Marchesi, N., Barbieri, A., Galeotti, N., & Pascale, A. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113257
Chronobiology of Cancer: How Aging Fuels Oncogenesis at the Molecular Level
Singh, A., Misra, A., & Zaheer, S. (2026) · Aging and Cancer · doi:10.1002/aac2.70027
Armartmuntree, N., Kaewlert, W., Aupatham, P., Buakaew, S., Sakonsinsiri, C., Lert-itthiporn, W., Pinlaor, S., & Thanan, R. (2026) · Oxidative Medicine and Cellular Longevity · doi:10.1155/omcl/3094707
“The regulation of cellular senescence involves extensively studied pathways, notably the p53/p21 cip1 and p16 INK4A /Rb pathways [34].”
Liang, X., Hou, M., Liu, Y., Yang, Y., Zhang, C., Zhang, Z., & Zhou, L. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05682-z
“Following geno - toxic stress such as ionizing radiation (IR), p53 is stabilized, activating transcription of p21 (CDKN1A), a potent cyclin-dependent kinase inhibitor that initiates stable G1/S cell cycle arrest [ 14 ].”
InfluentialGender differences and ethnic disparities in cardiac aging
Fatima, R., Rejili, M., Khan, Y., Eltaib, L., Maqbool, M., Rana, A. J., Fatima, S., Hussain, M. S., & Tufail, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45811-8.00018-0
Autophagy, mitophagy, and senescence in the heart
Aundhia, C. J., Afzal, M., Pandey, S. N., Siddique, M. R., Thapa, R., Bhat, A. A., Das, D. R., Singla, N., Singh, S. K., & Gupta, G. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45811-8.00001-5
Zinc homeostasis in cancer: From dynamic regulation to therapeutic potential
Pan, X., Ma, Y., Zou, D., Yan, Y., Hu, X., Miao, Y., Li, Y., Wu, H., Wei, M., & Tang, Y. (2026) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2026.101765
Xin, L., Guo, R., Sun, J., Su, Y., Cai, J., Li, W., Wan, Z., & Wang, J. (2026) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2026.2723920
Unveiling the role of p53 in the pathogenesis and treatment of autoimmune rheumatic diseases
Akbarzadeh, F., Farhadi, E., Vodjgani, M., Jamshidi, A., & Mahmoudi, M. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12666-1
“It also regulates senescence [12], angiogenesis [13], and fibrosis [ 14].”
Inflammatory Network Architecture Across Bone Marrow Failure: An Immune-Genetic Continuum
Beesetti, S. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl50689
Haba, D., Takizawa, C., Qin, Q., Tomida, S., Horinouchi, A., Sanada, H., & Nakagami, G. (2026) · The Journal of Dermatology · doi:10.1111/1346-8138.70486
Dependance of doxorubicin efficacy of on p21 protein level in tumor cells
Zamkova, M. A., Bruter, A. V., Kubekina, M. V., & Tatarskiy, V. V. (2026) · Advances in molecular oncology · doi:10.17650/2313-805x-2026-13-2-85-93
Multidimensional Regulatory Network of Cellular Senescence: From Mechanisms to Theranostics
Lv, Z., Liu, Y., Liu, Y., Tan, Y., Man, Y., Shuqing, D., Zhang, Z., Lee, L. P., Chen, Q., & Liu, Z. (2026) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6c00849
Chromosomal instability in cancer: sources, consequences and new therapeutic opportunities
Serpico, A. F., & Grieco, D. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02940-w
“278 Although senescent cells are irreversibly excluded from mitosis, they remain viable and develop metabolic alterations responsible for both favorable and dangerous outcomes.”
Podocyte-specific CerS6 Drives Renal Aging via C16 Ceramide-mediated p53-p21 SenescencePreprint
Zhang, G., Zhao, Q., Ding, Y., Ragi, N., Lee, N., Wang, Q., Lee, H. J., Zhang, S., Das, F., Kasinath, B. S., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10060621/v1
Matveeva, K. S., & Shevyrev, D. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188416
“In contrast, p16/pRb activation marks chronic stress and irreversible senescence [30–32].”
Kondratenko, N. D., Chelombitko, M. A., Zinovkina, L. A., Dashkevich, A. A., Prikhodko, A. S., Kuptsova, R. Y., Ziubina, E. P., Lyamzaev, K. G., & Zinovkin, R. A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198696
Chen, Y., Gong, T., Shan, Z., Lai, J., 徐以明, Zhao, H., & Zhu, L. (2026) · The FASEB Journal · doi:10.1096/fj.202602956rr
“The hallmarks of cellular senescence are senescence-associated β-galactosidase (SA- β-gal) activation and persistent cell cycle arrest caused by P21 and P16 INK4A upregulation [10].”
Jiménez-Martínez, M., de Jong, T. A., Houtman, M., Semmelink, J. F., Zelcer, N., van de Sande, M. G. H., Dankers, W., & van Baarsen, L. G. M. (2026) · RMD Open · doi:10.1136/rmdopen-2026-007143
Cellular senescence in multiple sclerosis: hallmarks, immunosenescence, and therapeutic implications
Yousef, A., Seubert, J. M., Power, C., & Nathoo, N. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1944657
“The main pathways involved in regulating cell cycle progression are p53/p21 and p16/Rb, which inhibit the cyclin-dependent kinases (CDKs) and block the activity of retino-blastoma (Rb) (39).”
Mojdehi, H. H., Habibollahi, H., & Faraji, N. (2026) · OBM Genetics · doi:10.21926/obm.genet.2604362
Croix, A. E. L., Gouveia, M. E. T., Bertone, P. M., Nemanic, N. M., Bahney, C. S., & Hixon, K. R. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.09.020
“Radiation-induced senescence in bone is regulated primarily through p53/p21 and p16/pRB signaling pathways [83,198,199].”
Nuha, N., Higgins, C. E., Higgins, S. P., Samarakoon, R., & Higgins, P. J. (2026) · Biomolecules · doi:10.3390/biom16101517
“In normal cells, PAI-1 is part of a protective cellular response to damage, inducing cell cycle arrest and senescence in the presence of genotoxic stress through the p53/p21 pathway [21,22].”
Molonia, M. S., Trischitta, S., Salamone, F. L., Saija, A., Speciale, A., & Cimino, F. (2026) · Toxicology · doi:10.1016/j.tox.2026.154617
Wu, Y., Shi, Y., Xiao, F., Liu, A., Li, X., Xia, N., & Zhang, H. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.112397
Stoffel, M., Baschun, K., Kehl, M., Ellinger, J., Klümper, N., Kadzik, S., Winterhagen, F. I., Ritter, M., Hölzel, M., Kristiansen, G., et al. (2026) · BMC Cancer · doi:10.1186/s12885-026-17178-6
“…the major regulators of senescence, the p16INK4a-Rb pathway plays a central role [14, 15]. p16 expression has been widely used as a senescence-associated marker in different physiological and pathological settings, although its biological significance may vary depending on tissue context [16, 17].”
BindingDB (2025) · UC San Diego · doi:10.7270/q2571hks
Metadata
- Authors
- Mijit, M., Caracciolo, V., Melillo, A., Amicarelli, F., & Giordano, A.
- Affiliations
- University of Siena (IT)
- Temple University (US)
- University of L'Aquila (IT)
- Corresponding author
- Giordano, Antonio
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2020-03-08
- Volume
- 10
- Issue
- 3
- Pages
- 420
- ISSN
- 2218-273X (ISSN-L)
- PMC
- PMC7175209
- OpenAlex
- W3010215457
- Cited by
- 639
- References
- 128
- Citations by year
- 2026: 100 · 2025: 142 · 2024: 126 · 2023: 96 · 2022: 92 · 2021: 64 · 2020: 17
- FWCI
- 8.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomolecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- TUScholarShare (Temple University) (submittedVersion, cc-by)
- UniTERAMO Research Catalog (University of Teramo) (submittedVersion, other-oa)
- Use Siena air (University of Siena) (submittedVersion, other-oa)
- Funders
- H2020 Marie Skłodowska-Curie Actions (713714)
- Commonwealth of Pennsylvania, Department of Health (290228/13650)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- p53, cellular senescence, DNA damage response, cell cycle arrest, apoptosis, genome stability, aging, antitumor immunity, senescence-associated secretory phenotype, inflammatory cytokines, tumor microenvironment, tissue dysfunction
- MeSH terms
- Animals, DNA Damage, DNA Repair, Humans, Tumor Suppressor Protein p53, Cellular Senescence, Cell Cycle Checkpoints, Cellular Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.